Antiadhesion agents against Gram-positive pathogens

被引:0
|
作者
Cascioferro, Stella [1 ]
Cusimano, Maria Grazia [1 ]
Schillaci, Domenico [1 ]
机构
[1] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy
关键词
antiadhesion agents; antivirulence drugs; Gram-positive pathogens; WALL TEICHOIC-ACID; PROTEIN ANCHORING TRANSPEPTIDASE; FIBRONECTIN-BINDING PROTEIN; STAPHYLOCOCCUS-AUREUS SORTASE; STREPTOCOCCUS-SUIS; CELL-WALL; LIPOTEICHOIC ACID; SURFACE-PROTEINS; BACTERIAL ADHESION; EPITHELIAL-CELLS;
D O I
10.2217/FMB.14.56
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A fundamental step of Gram-positive pathogenesis is the bacterial adhesion to the host tissue involving interaction between bacterial surface molecules and host ligands. This review is focused on antivirulence compounds that target Gram-positive adhesins and on their potential development as therapeutic agents alternative or complementary to conventional antibiotics in the contrast of pathogens. In particular, compounds that target the sortase A, wall theicoic acid inhibitors, carbohydrates able to bind bacterial proteins and proteins capable of influencing the bacterial adhesion, were described. We further discuss the advantages and disadvantages of this strategy in the development of novel antimicrobials and the future perspective of this research field still at its first steps.
引用
收藏
页码:1209 / 1220
页数:12
相关论文
共 50 条
  • [41] New agents for Gram-positive bacteria
    Bhavnani, SM
    Ballow, CH
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2000, 3 (05) : 528 - 534
  • [43] Sortase, a universal target for therapeutic agents against Gram-positive bacteria?
    Cossart, P
    Jonquières, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5013 - 5015
  • [44] Nanocomposites with ornidazole—antibacterial and antiadhesive agents against Gram-positive and Gram-negative bacteria
    I. Furtat
    M. Lupatsii
    T. Murlanova
    P. Vakuliuk
    A. Gaidai
    O. Biliayeva
    H. Sobczuk
    A. Golub
    [J]. Applied Nanoscience, 2020, 10 : 3193 - 3203
  • [45] In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens
    Pucci, Michael J.
    Cheng, Jijun
    Podos, Steven D.
    Thoma, Christy L.
    Thanassi, Jane A.
    Buechter, Douglas D.
    Mushtaq, Gohar
    Vigliotti, Gerald A., Jr.
    Bradbury, Barton J.
    Deshpande, Milind
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1259 - 1267
  • [46] Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
    Streit, JM
    Sader, HS
    Fritsche, TR
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (04) : 307 - 310
  • [47] 10 Years of Linezolid (Zyvoxid®) Strong and highly effective against gram-positive pathogens
    不详
    [J]. ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2011, 52 : 777 - 777
  • [48] CHARACTERIZATION OF LEUKIN - AN ANTIBACTERIAL FACTOR FROM LEUCOCYTES ACTIVE AGAINST GRAM-POSITIVE PATHOGENS
    SKARNES, RC
    WATSON, DW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1956, 104 (06): : 829 - 845
  • [49] RETRACTED: New antimicrobial peptide active against Gram-positive pathogens (Retracted Article)
    Jasir, A
    Kasprzykowski, F
    Lindström, V
    Schalén, C
    Grubb, A
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 119 : 74 - 76
  • [50] Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
    Bouza, Emilio
    Burillo, Almudena
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (05) : 401 - 407